Literature DB >> 11231944

Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice.

C Veltkamp1, S L Tonkonogy, Y P De Jong, C Albright, W B Grenther, E Balish, C Terhorst, R B Sartor.   

Abstract

BACKGROUND & AIMS: Normal resident bacteria are required for development of colitis in several rodent models. We determined whether bacterial stimulation is necessary for both induction and perpetuation of mucosal inflammation and T-cell activation in Tg(epsilon26) mice, in which transplantation of wild-type bone marrow (BM-->Tg(epsilon26)) causes colitis under specific pathogen-free (SPF) conditions.
METHODS: BM from (C57BL/6 X CBA/J) F1 mice was transplanted into germfree (GF) or SPF Tg(epsilon26) mice. Mesenteric lymph node (MLN) cells from these mice were then transferred into SPF or GF recipients. Colitis and activation of MLN cells were measured by histologic scores, membrane marker analysis, and intracellular cytokine staining. Cytokine secretion by MLN cells stimulated by anti-CD3 or by luminal or epithelial antigens was measured by ELISA.
RESULTS: Colitis did not develop when BM was transferred into GF recipient mice (BM-->GF Tg(epsilon26)). T lymphocytes that secreted interferon gamma upon activation were present in the MLN of BM-->GF Tg(epsilon26) mice, albeit in lower frequency than in control BM-->SPF Tg(epsilon26) mice. Furthermore, transfer of MLN cells from BM-->SPF Tg(epsilon26) mice into SPF Tg(epsilon26) recipients induced active colitis, but not if the same cells were transferred into GF Tg(epsilon26) recipients. Although CD4 T cells were detected in the colonic mucosa of GF recipients, no inflammation was observed for at least 31 weeks. In a reciprocal experiment, MLN cells from BM-->GF Tg(epsilon26) mice without colitis transferred disease to SPF Tg(epsilon26) recipients within 2-4 weeks.
CONCLUSIONS: Activated T cells are present in the mucosa of BM-->GF Tg(epsilon26) mice but are incapable of inducing disease unless colonic bacteria are present. Moreover, pathogenic T cells require the continuous presence of colonic bacteria to sustain colitis.

Entities:  

Mesh:

Year:  2001        PMID: 11231944     DOI: 10.1053/gast.2001.22547

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

Review 1.  Layers of mutualism with commensal bacteria protect us from intestinal inflammation.

Authors:  C Mueller; A J Macpherson
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

Review 2.  Antibiotic therapy for Crohn's disease: a review.

Authors:  Simon Lal; A Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

3.  T cell-mediated oral tolerance is intact in germ-free mice.

Authors:  K L W Walton; J A Galanko; R Balfour Sartor; N C Fisher
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

4.  Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.

Authors:  Carol A Albright; R Balfour Sartor; Susan L Tonkonogy
Journal:  Immunol Lett       Date:  2009-03-03       Impact factor: 3.685

5.  Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.

Authors:  Bo Liu; Susan L Tonkonogy; R Balfour Sartor
Journal:  Gastroenterology       Date:  2011-04-30       Impact factor: 22.682

Review 6.  The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond.

Authors:  Mircea T Chiriac; Mousumi Mahapatro; Markus F Neurath; Christoph Becker
Journal:  Visc Med       Date:  2017-04-07

7.  Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

Authors:  James P Moran; Jens Walter; Gerald W Tannock; Susan L Tonkonogy; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

8.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation.

Authors:  B Siegmund; H A Lehr; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

10.  Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.

Authors:  Arunan S Vamadevan; Masayuki Fukata; Elizabeth T Arnold; Lisa S Thomas; David Hsu; Maria T Abreu
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.